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Introduction: Tissue-engineered skeletal muscle constructs should be designed to generate contractile force
with directional movement. Because electrical impulses from a somatic nervous system are crucial for in vivo
skeletal muscle development, electrical pulse stimulation (EPS) culture as an artiﬁcial exercise is essential to
fabricate functional skeletal muscle tissues in vitro. To further improvemuscle functions, the activation of cell-
signaling pathways frommyogenic growth factors, such as insulin-like growth factor (IGF)-I, is also important.
Because tissue-engineered skeletal muscle constructs should maintain a high cell-dense structure, the
expression of an anti-apoptotic factor, such as B-cell lymphoma 2 (Bcl-2), could be effective in preventing cell
death.
Methods: In the present study, myoblasts were genetically modiﬁed with inducible expression units of
IGF-I and Bcl-2 genes, and the tissue-engineered skeletal muscle constructs fabricated from the myo-
blasts were cultured under continuous EPS.
Results: Overexpression of IGF-I gene induced muscular hypertrophy in the muscle tissue constructs, and
Bcl-2-overexpressing myoblasts formed signiﬁcantly cell-dense and viable muscle tissue constructs.
Furthermore, the combination of IGF-I and Bcl-2 gene transfer with EPS culture highly improved the
force generation of the tissue-engineered skeletal muscle constructs.
Conclusions: This approach has the potential to yield functional skeletal muscle substitutes with high
force generation ability.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Contractile force generation is the most important character-
istic of muscles. Tissue-engineered skeletal muscle constructs
should be designed to generate contractile force with directional
movement. The functional units of skeletal muscles are fascicles,
composed of dense and unidirectional muscle ﬁbers surroundedag-TE, magnetic force-based
.
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ative Medicine. Production and hoby muscular extracellular matrix (ECM) components such as type I
collagen and laminin [1]. For fabrication of skeletal muscle tissues
therefore, high cell density for cell fusion of myoblasts, unidirec-
tional cell alignment to exert contractile force, and supplementa-
tion of muscular ECM to give the tissue constructs both structure
and strength must be achieved [2]. We previously reported a
fabrication procedure of functional skeletal muscle tissue con-
structs using a magnetic force-based tissue engineering (Mag-TE)
technique [3]. Myoblasts were magnetically labeled with func-
tionalized magnetite nanoparticles, which enabled us to accu-
mulate cells by magnetic force to form a densely packed,
uniformly aligned, and thin fascicle-like structure surrounded by
ECM, compared with muscle tissue constructs fabricated by a
conventional gel-based technique [4]. The tissue-engineered
skeletal muscle constructs were electrically excitable to generate
contractile force [5].sting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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skeletal muscle tissue development and maturation [6]. We hy-
pothesized that artiﬁcial electrical pulse stimulation (EPS) mimics
the electrical cues in the in vivo niche of fascicles, allowing the
fabrication of functional skeletal muscle tissue constructs in vitro. In
our previous study [4], a methodology for controlling EPS parame-
ters to develop in vitro functional tissue-engineered muscle con-
structs was established. We optimized an EPS protocol inwhich the
tissue-engineered skeletal muscle constructs were stimulated with
continuous electrical pulses of 0.3V/mmamplitude, 4mswidth, and
1 Hz frequency, resulting in a 4.5-fold increase in force [4].
Insulin-like growth factor (IGF)-I is a peptide growth hormone
that has a primary role in promoting growth and differentiation of
skeletal muscles [7]. IGF-I is involved in muscular processes such as
muscle regeneration, myotube formation and myotube hypertro-
phy. In a previous study [8], we showed that overexpression of the
IGF-I gene in mouse myoblast C2C12 cells promoted proliferation
and differentiation of cells and induced hypertrophy of myotubes.
Moreover, contractile force generation of tissue-engineered skel-
etal muscle constructs was enhanced by IGF-I gene expression.
In skeletal muscle tissue engineering, forming perfusable blood
vessels within artiﬁcial tissue constructs to supply oxygen and
nutrients remains challenging [9]; and limited cell viability in cell-
dense tissue constructs may restrict contractile force generation. In
our previous study [10], C2C12 cells were genetically modiﬁed with
an anti-apoptotic B-cell lymphoma 2 (Bcl-2) gene to prevent cell
death in the tissue constructs. Bcl-2-overexpressing muscle tissue
constructs exhibited a signiﬁcantly larger number of viable cells
within the tissue constructs, compared to control muscle tissue
constructs without gene modiﬁcation. Moreover, Bcl-2-
overexpressing muscle tissue constructs generated a signiﬁcantly
higher contractile force, which was attributable to the increased
number of viable myoblasts in the tissue constructs.
These results prompted us to combine IGF-I and Bcl-2 gene
transfer to myoblasts under EPS culture, and examine the effects of
IGF-I and Bcl-2 gene expression in myoblasts on contractile force
generation of tissue-engineered skeletal muscle constructs.
2. Materials and methods
2.1. Cell culture
Mouse myoblast C2C12 cells (passage 19 or 20; Riken, Ibaraki,
Japan) [11] were grown in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and
antibiotics (100 U/mL penicillin G potassium and 0.1 mg/mL
streptomycin sulfate). For induction of myogenic differentiation,
growth medium was replaced with DMEM supplemented with 2%
calf serum for two-dimensional cell culture or 0.4% Ultroser G (Pall,
Port Washington, NY, USA) for three-dimensional tissue culture.
Cells were grown in a humidiﬁed 37 C incubator with 5% CO2 in air.
2.2. Retroviral vector production and infection
MoMLV-derived mouse stem cell virus (MSCV)-based retroviral
vectors were used for gene transfer into C2C12 cells. The Tet-On
system (Clontech, Mountain View, CA, USA) was incorporated
into the retroviral vectors for inducible expression of IGF-I and Bcl-
2 genes. Retroviral vectors pseudotyped with the vesicular stoma-
titis G protein (VSV-G) were produced by transient transfection of
293FT cells with three plasmid DNAs, comprising a retroviral vector
plasmid (pQMSCV/EGFP-CMV-rtTA-WPRE [8], pQMSCV/EGFP-TRE-
IGF-WPRE [8] or pQMSCV/EGFP-TRE-Bcl-WPRE [10]), pcDNA4-
gag/pol [12] and pLP/VSV-G [12], using the lipofection reagent
Lipofectamine 2000 (Thermo Fisher Scientiﬁc, Waltham, MA, USA).The culture medium containing viral vector particles was collected,
ﬁltered through a 0.45-mm cellulose acetate ﬁlter (Advantec, Tokyo,
Japan) and used for infection. For the retroviral infection, C2C12
cells (2.5  105) were seeded into a 100-mm tissue culture dish
(Thermo Fisher Scientiﬁc) and cultured for 24 h. Subsequently, the
medium was replaced with 10 mL of retroviral solution containing
retroviral vectors encoding rtTA (MSCV/EGFP-CMV-rtTA-WPRE
[8]), IGF-I (MSCV/EGFP-TRE-IGF-WPRE [8]) and Bcl-2 (MSCV/EGFP-
TRE-Bcl-WPRE [10]) expression cassettes. The cells were then
cultured in the presence of polybrene (8 mg/mL) for 6 h, resulting in
the generation of C2C12 cells capable of doxycycline (Dox)-induc-
ible IGF-I and Bcl-2 expression (C2C12/IGF&Bcl cells). For all of the
retroviral infections, the viral titers against C2C12 cells were
determined by ﬂow cytometry using a FACSCalibur (BD Biosciences,
Franklin Lakes, NJ, USA). The viral titers at the infection were
approximately 2.5  105 IU/mL for each vector.
2.3. Fabrication of artiﬁcial skeletal muscle tissues using Mag-TE
Magnetite cationic liposomes (MCLs) were prepared from
colloidal magnetite (Fe3O4; average particle size, 10 nm) and a lipid
mixture consisting of N-(a-trimethylammonioacetyl)-didodecyl-D-
glutamate chloride, dilauroylphosphatidylcholine, and dio-
leoylphosphatidylethanolamine, in a molar ratio of 1:2:2 [13]. To
label C2C12 cells magnetically, 3  106 cells were seeded in 100-
mm tissue culture dishes containing 10 mL growth medium, in
the presence of MCLs (net magnetite concentration, 100 pg/cell),
and incubated for 6 h to allow MCL uptake.
Skeletal muscle tissue constructs were fabricated by the Mag-TE
technique [14]. Brieﬂy, a collagen solution was prepared by mixing
type I collagen solution (NittaGelatin, Osaka, Japan),10DMEMand
neutralization buffer (0.05 M NaOH) at a volume ratio of 8:1:1. An
MCL-labeled cell suspension (1 106 cells in 50 mL) wasmixedwith
an ECM precursor solution composed of collagen solution (70 mL;
ﬁnal concentration, 0.5 mg/mL), FBS (15 mL) and Matrigel basement
matrix (15 mL; BD Biosciences). Subsequently, the mixture was
added into wells of a 24-well ultra-low attachment plate (150 mL/
well, Corning, New York, NY, USA) with a polycarbonate cylinder
(diameter,12mm;height, 5mm)ﬁxed at the centerof eachwell, and
a neodymiummagnet (diameter, 30mm;magnetic induction, 0.4 T)
was placed under thewell. Thereafter, growthmediumwas added to
eachwell. Onedayafter cell seeding, the cell layer shrunkaround the
cylinder, resulting in the formation of a ring-shaped artiﬁcial skel-
etalmuscle tissue construct. The cellular ringwas removed from the
cylinder and hooked around two stainless-steel pins (Shiga, Tokyo,
Japan) that were positioned 6 mm apart from one another. The
cellular tissues were cultured using differentiation medium (day 0)
in wells of a 6-well culture plate for 7 days, to induce myogenic
differentiation to fabricate skeletal muscle tissue constructs. To
induce IGF-I and Bcl-2 genes, the tissue constructs were cultured in
the presence of Dox (1 mg/mL) from day 0 at the beginning of dif-
ferentiation culture. The mediumwas replaced with fresh medium
every day. To measure IGF-I secretion quantitatively, the culture
media were analyzed using a mouse IGF-I ELISA kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer's protocol.
2.4. Electric pulse stimulation during tissue culture
Four days after the induction of differentiation (day 4), the
artiﬁcial skeletal muscle tissues inwells of 6-well plate were placed
in a chamber (C-Dish; IonOptix, Milton, MA, USA) to apply EPS [6].
The tissue constructs were placed between two carbon electrodes
(20.3 mm apart). Bi-directional electric pulses were generated by a
function generator (NF Corporation, Kanagawa, Japan), alternator
(Matsusada Precision, Shiga, Japan), and ampliﬁer (Apex
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muscle constructs were stimulated with continuous electrical
pulses of 0.3 V/mm amplitude, 4mswidth, and 1 Hz frequency for 3
days (from day 4 through day 7).
2.5. Histology
For immunostaining, tissues were washed three times with
phosphate-buffered saline (PBS) and ﬁxed in 4% paraformaldehyde
(PFA) for 15 min. They were then permeabilized in PBS containing
0.2% Triton X-100 for 15 min, washed three times with PBS, and
blocked in PBS containing 1% (w/v) bovine serum albumin (BSA) for
30 min. The specimens were probed with a primary antibody
against a-actinin (A-7811, monoclonal anti-a-actinin EA-53; Sig-
maeAldrich, St. Louis, MO, USA) for 45min. They were thenwashed
three times with PBS and immersed in PBS containing 1% BSA, an
Alexa546-conjugated secondary antibody (Life Technologies,
Carlsbad, CA, USA), and 40,6-diamidino-2-phenylindole (DAPI) for
45 min. The specimens were washed three times with PBS and
observed under an FV10i confocal laser scanning microscope
(Olympus, Tokyo, Japan). Microscopic images of ﬁve ﬁelds in each of
three individual tissue constructs per sample were captured for
subsequent analysis. The width of a-actinin-positive myotubes was
measured using ImageJ software (NIH, Bethesda, MD, USA).
For hematoxylin and eosin staining (H&E), tissues were washed
with PBS, ﬁxed in 4% PFA in PBS, and embedded in parafﬁn. Thin
sections (4 mm) were prepared, stained with H&E, and then
observed under a BZ-9000 microscope (Keyence, Tokyo, Japan).
Microscopic images of three ﬁelds in each of three individual tissue
constructs per sample were captured, and the number of nuclei in
the tissue constructs was counted.
2.6. Tension measurement
Two carbon electrodes were placed 18 mm apart at opposite
sides of a well of a 4-well tissue culture plate. A skeletal muscle
tissue construct was hooked around two stainless-steel pins. One
pin was attached to a force transducer (AE-801; SensorOne, Sau-
salito, CA, USA) and the other was ﬁxed to a silicone sheet placed on
the bottom of a well of the culture plate. Electrical pulse generation
was controlled with specially designed LabView software (National
Instruments, Austin, TX, USA). For measuring twitch contractions,
the tissue samples were stimulated with an electrical pulse of 18 V
with a width of 10 ms. For measuring tetanic contractions, the
tissue samples were stimulated with electrical pulses at voltage,
18 V; width, 10 ms; frequency, 50 Hz; duration, 2 s.
2.7. Statistical analysis
Statistical comparisons were evaluated using the WinStat soft-
ware (LightStone, Tokyo, Japan). The differences between two
groups were analyzed using the ManneWhitney rank sum test.
Differences in all statistical comparisonwere considered signiﬁcant
at levels with P values < 0.05.
3. Results
3.1. Myogenic hypertrophy in tissue-engineered skeletal muscle
constructs
A retroviral vector system allowing Tet-On inducible gene
expression was used in this study. The IGF-I productivities of
C2C12/IGF&Bcl cells in the absence [C2C12/IGF&Bcl (Dox)] and
presence [C2C12/IGF&Bcl (Doxþ)] of Dox were 0.07 ± 0.03 and
2.49 ± 0.11 ng/(mL day), respectively. Because muscle hypertrophy,
which is an increase in size of skeletal muscle through a growth insize of myotubes, is involved in the contractile force generation of
the muscle in vivo, myotubes in the tissue-engineered skeletal
muscle constructs at day 7 were stained with speciﬁc antibodies
against a-actinin (Fig. 1A) and myotube width was measured
(Fig. 1B). C2C12/IGF&Bcl (Doxþ) muscle tissue constructs exhibited
a greater myotube width (41.9 ± 3.5 mm versus 24.7 ± 3.6 mm;
P < 0.05) than C2C12/IGF&Bcl (Dox) muscle tissue constructs. EPS
also lead to increased myotube width in C2C12/IGF&Bcl (Dox)
muscle tissue constructs, and the combination of transgene
expression and EPS induced slightly but signiﬁcantly greater
myotube width (52.8 ± 2.5 mm) than EPS alone (47.0 ± 0.8 mm;
P < 0.05) and transgene expression alone (41.9 ± 3.5 mm; P < 0.05),
respectively. Interestingly, obvious striation patterns containing
sarcomeric a-actinin were observed in EPS tissue constructs with
and without Dox addition (Fig. 1A).
3.2. Cell survival in tissue-engineered skeletal muscle constructs
H&E staining revealed that the average diameter of C2C12/
IGF&Bcl muscle tissue constructs was 495 ± 82 mm. As shown in
Fig. 2A, C2C12/IGF&Bcl muscle tissue constructs consisted of an
outer region with densely packed cells and a relatively acellular
central core region. The outermost cell layerwas composed of highly
oriented myotubes, as shown in Fig. 1A. In C2C12/IGF&Bcl (Doxþ)
muscle tissue constructs, viable cells were observed even at the
relatively acellular central core region. Fig. 2B shows the number of
nuclei in C2C12/IGF&Bcl muscle tissue constructs. Signiﬁcant dif-
ferences between the numbers of nuclei in C2C12/IGF&Bcl (Dox)
and C2C12/IGF&Bcl (Doxþ) muscle bundles were observed, sug-
gesting that Bcl-2 overexpression prevented cell death within the
tissues. However, EPS did not affect the number of nuclei.
3.3. Contractile properties of tissue-engineered skeletal muscle
constructs
C2C12/IGF&Bcl muscle tissue constructs were stimulated with
electrical pulses to evaluate contractile properties. Fig. 3A shows
the force generation proﬁles in response to electrical stimulation. A
brief contractile response (twitch), occurred after applying an
electrical pulse of 18 V with a width of 10 ms, while the additional
activation of contractile elements (tetanus), was observed by
repeated electrical stimulation with a higher frequency (voltage,
18 V; width, 10 ms; frequency, 50 Hz; duration, 2 s), indicating
similar properties to natural skeletal muscle tissues. The maximum
twitch and tetanic forces produced by C2C12/IGF&Bcl muscle tissue
constructs on day 7 are shown in Fig. 3B. In this experiment, C2C12/
IGF cells and C2C12/Bcl cells were also generated by retroviral
transduction using MSCV/EGFP-TRE-IGF-WPRE [8] and MSCV/
EGFP-TRE-Bcl-WPRE [10], respectively. The IGF-I secretion levels
of C2C12/IGF cells in the absence [C2C12/IGF (Dox),
0.05 ± 0.01 ng/(mL day)] and presence [C2C12/IGF (Doxþ),
2.30 ± 0.07 ng/(mL day)] of Dox were similar to those of C2C12/
IGF&Bcl cells. Consistent with our previous results, C2C12/IGF
(Doxþ) and C2C12/Bcl (Doxþ) muscle tissue constructs generated a
signiﬁcantly (P < 0.05) higher physical force by the twitch and
tetanus contractions than C2C12/IGF (Dox) and C2C12/Bcl (Dox)
muscle tissue constructs, respectively. EPS also enhanced contrac-
tile force generation. Unexpectedly, the combination of IGF-I and
Bcl-2 gene overexpression [C2C12/IGF&Bcl (Doxþ)] did not
enhance the contractile force as compared with IGF-I alone [C2C12/
IGF (Doxþ)] and Bcl-2 alone [C2C12/Bcl (Doxþ)], when they were
cultured without EPS. When the tissue constructs were cultured
under EPS, C2C12/IGF&Bcl (Doxþ) muscle tissue constructs
generated a signiﬁcantly (P < 0.05) higher physical force than
C2C12/IGF (Doxþ) and C2C12/Bcl (Doxþ) muscle tissue constructs,
Fig. 1. Myogenic hypertrophy in tissue-engineered skeletal muscle constructs. (A) Fluorescence microscopy images of a-actinin-positive myotubes (red) at day 7. Nuclei were
stained by DAPI (blue). C2C12/IGF&Bcl muscle tissue constructs were cultured in the presence (Doxþ) or absence (Dox) of doxycycline and with (EPSþ) or without (EPS)
electrical pulse stimulation culture in differentiation medium. Inset: Magniﬁed image of area in white rectangle. (B) Quantitative image analysis of myotube hypertrophy. The data
are expressed as mean ± SD of four constructs. *P < 0.05.
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IGF&Bcl (Dox) muscle tissue constructs cultured without EPS.
These results indicate that the combination of IGF-I and Bcl-2 gene
transfer to myoblasts and EPS culture improved contractile force
generation of tissue-engineered skeletal muscle constructs.
4. Discussion
In this study, we demonstrated the combined effects of IGF-I and
Bcl-2 gene overexpression with EPS culture on force generation
capability of artiﬁcial skeletal muscle tissue constructs. Contractile
force generation is the most important feature of muscles. Muscle
hypertrophy is involved in contractile force generation of muscles
[15], and we examined myotube width in the tissue-engineered
skeletal muscle constructs as an indicator of the contractile force
generation ability (Fig. 1). IGF-I is involved in muscle hypertrophy
through either autocrine or paracrine mechanisms [16]; and we
previously showed that myotubes induced from C2C12/IGF (Doxþ)
cells exhibited a greater width than control myotubes induced fromnormal C2C12 cells [8]. In the present study, C2C12/IGF&Bcl (Doxþ)
muscle tissue constructs possessed a greater myotube width than
C2C12/IGF&Bcl (Dox) muscle tissue constructs (Fig. 1B). Autocrine
and/or paracrine IGF-I activates Akt via phosphoinositide 3-kinase,
promoting activation of mammalian targets rapamycin and
glycogen synthase kinase-3b, which play crucial roles in skeletal
muscle hypertrophy [17]. In a previous study [8], we showed that
the level of phosphorylated Akt increased in the C2C12/IGF (Doxþ)
muscle tissue constructs, suggesting that IGF-I overexpression
induced Akt activation occurs in the C2C12/IGF&Bcl (Doxþ) muscle
tissue constructs. Interestingly, EPS also leads to increasedmyotube
width in the C2C12/IGF&Bcl muscle tissue constructs with or
without Dox addition. It was reported that EPS-mediated muscle
contraction activates Akt [18]; however the mechanism for this
remains to be determined.
In the present study, the levels of contractile force generation
ability (Fig. 3B) were not fully consistent with those of myotube
width (Fig. 1B). A slight but signiﬁcant difference in myotube width
was observed between C2C12/IGF&Bcl (Doxþ) muscle tissue
Fig. 2. Cell survival in tissue-engineered skeletal muscle constructs. (A) Hematoxylin and eosin-stained images of cross-sections of C2C12/IGF&Bcl muscle tissue constructs at day 7.
C2C12/IGF&Bcl muscle tissue constructs were cultured in the presence (Doxþ) or absence (Dox) of doxycycline and with (EPSþ) or without (EPS) electrical pulse stimulation
culture in differentiation medium. (B) The number of nuclei in C2C12/IGF&Bcl muscle tissue constructs at day 7. The data are expressed as mean ± SD of three constructs. *P < 0.05.
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Fig. 1B), whereas the twitch force generated by C2C12/IGF&Bcl
(Doxþ) muscle tissue constructs with EPS was two times higher
than that without EPS (Fig. 3B). An obvious difference between
myotubes with and without EPS was sarcomere formation,
whereby EPS culture induced well-developed sarcomere structure
in the myotubes (Fig. 1A). Thus, contractile force generation capa-
bility reﬂects the total aspect of muscle functions, including
myogenic differentiation, muscle cell numbers, and sarcomere
structure within muscle cells, indicating that the contractility data
presented in terms of force is the most important to evaluate
tissue-engineered skeletal muscle construct function.
We evaluated the combination of IGF-I and Bcl-2 gene transfer in
terms of contractile force generation. Without EPS, overexpression
of both IGF-I and Bcl-2 genes did not further enhance contractile
force generation compared with overexpression of IGF-I alone or
Bcl-2 alone. With EPS, C2C12/IGF&Bcl (Doxþ) muscle tissue con-
structs generated a signiﬁcantly (P<0.05) higher physical force than
C2C12/IGF (Doxþ) and C2C12/Bcl (Doxþ) muscle tissue constructs
(Fig. 3B). Tissue-engineered skeletal muscle constructs should be
designed tomimic thenativemuscle. Becauseelectrical impulses arecrucial for in vivo skeletal muscle development, we believe that EPS
is essential to fabricate functional skeletal muscle tissues available
for in vitro applications, such as in drug screening for muscular
diseases.
One of the obstacles to the clinical use of tissue-engineered
skeletal muscle constructs is limited force generation capacity
[19]. The recent technological progress in gene therapy has opened
new horizons in the ﬁeld of regenerative medicine and tissue en-
gineering [20], and genetically engineered cells offer solutions to
severe problems in medicine. In the present study, C2C12/IGF&Bcl
(Doxþ) muscle tissue constructs cultured with EPS improved the
contractile force generation. However, themaximum twitch force is
still low (Fig. 3B), which corresponds to ~2.5% of adult mammalian
skeletal muscle [21,22]. A possible reason for the low contractile
force is attributable to low density of myotubes within the tissue
constructs (Fig. 2A), compared with in vivo skeletal muscle. Thick
engineered tissues may be produced by incorporating perfusable
blood vessels for efﬁcient oxygen and nutrient supply in vitro [9,23].
Thus, a perfusion culture system may be effective to increase
myotube density within the tissue constructs and to improve the
contractile force generation.
Fig. 3. Contractile properties of tissue-engineered skeletal muscle constructs. (A) A representative peak twitch force using a single electric pulse (red line; voltage: 0.83 V/mm,
width: 10 ms) and fusion of tetanus (blue line; voltage: 0.83 V/mm, width: 10 ms; frequency: 50 Hz, duration: 2 s) generated by C2C12/IGF&Bcl muscle tissue constructs with EPS
culture at day 7. (B) Maximum twitch (left) and tetanus (right) forces of muscle tissue constructs. Muscle tissue constructs were cultured in the presence (Doxþ) or absence (Dox)
of doxycycline and with (EPSþ) or without (EPS) electrical pulse stimulation culture in the differentiation medium. White columns, C2C12/IGF; gray columns, C2C12/Bcl; black
columns, C2C12/IGF&Bcl muscle tissue constructs. The data are expressed as mean ± SD of three constructs. *P < 0.05.
K. Ikeda et al. / Regenerative Therapy 3 (2016) 38e44 43The tissue-engineered skeletal muscle constructs fabricated
from mouse myoblast C2C12 cells in this study exhibited the
skeletal muscle functions such as contractile force generation.
Dennis et al. reported that tissue-engineered skeletal muscle con-
structs fabricated from primary mouse myoblasts showed higher
contractile force generation than tissue constructs prepared from
C2C12 cells [24]. This suggests that the use of primary myoblasts is
a promising approach to improve functions of tissue-engineered
skeletal muscle constructs. For the clinical application, tissue-
engineered skeletal muscle constructs should be fabricated using
primary myoblasts or myoblasts derived from stem cells such as
induced pluripotent stem cells [25].
In conclusion, we fabricated tissue-engineered skeletal muscle
constructs with high contractile force generation ability using
genetically modiﬁed myoblasts and EPS culture. The approach we
have proposed in this study indicates the potential to yield func-
tional skeletal muscle substitutes with high force generation ability.Conﬂict of interest
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